Purpose
to enable the discovery of effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease, by integrating plasma and lesion pharmacokinetic profiling of existing drugs, hits, leads, and clinical development candidates.
Grantee
Division
Global Health
Date
OCTOBER 2012
Region served
GLOBAL
Committed amount
$2,518,838
Grant topic
Tuberculosis
Duration (months)
48
Grantee location
Newark, New Jersey, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.